SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biogen Canada Updates Draft Recommendation on Spinraza Reimbursement

Biogen Canada provided an update on a Canadian draft recommendation supporting expanded public reimbursement of Spinraza for people with SMA.

Related stories